- Funding to prepare Mymetics' cold chain independent needle free mucosal virosome HIV vaccine candidate for clinical trials
- Collaboration with Texas Biomedical Research Institute and University of Louisiana at Lafayette
- Total award USD 8.5 million over 5 years, with USD 1.9 million budget in the first year
PR Newswire
EPALINGES, Switzerland, April 29, 2019